Cargando…
Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes
INTRODUCTION: Insulin-like growth factor 1 (IGF-1) has been connected with development of pancreatic ductal adenocarcinoma (PDAC). AIM: To evaluate the serum concentration levels of IGF-1 and insulin-like growth factor binding protein 2 (IGFBP-2) in patients with chronic pancreatitis (CP) and PDAC....
Autores principales: | Włodarczyk, Barbara, Borkowska, Anna, Włodarczyk, Przemysław, Małecka-Panas, Ewa, Gąsiorowska, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112262/ https://www.ncbi.nlm.nih.gov/pubmed/33986886 http://dx.doi.org/10.5114/pg.2020.95091 |
Ejemplares similares
-
Insulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps
por: Janiak, Adam, et al.
Publicado: (2013) -
CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation
por: Wlodarczyk, Barbara, et al.
Publicado: (2023) -
Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer
por: Gasiorowska, A., et al.
Publicado: (2015) -
Procoagulant Disorders in Patients with Newly Diagnosed Pancreatic Adenocarcinoma
por: Talar-Wojnarowska, Renata, et al.
Publicado: (2020) -
Serum insulin‐like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma‐associated malnutrition and muscle wasting
por: Dong, Jie, et al.
Publicado: (2021)